eXoZymes, Inc. (EXOZ) 是一家上市公司 属于 医疗保健 板块，经营于 生物科技 行业. 公司总部位于 Monrovia, NV, 美国. 现任CEO为 Michael Heltzen.
EXOZ 拥有 IPO日期为 2024-11-13, 31 名全职员工, 在 NASDAQ Global Market, 市值为 $91.91M.
eXoZymes, Inc. operates as a synthetic biochemical company in the United States. The company develops SimplePath, a platform that produces chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds. Its platform also comprises one or more module which consist of one or more enzymes that work together to perform a defined biocatalytic conversion. The company was founded in 2014 and is headquartered in Monrovia, California.
